shtaywy abdalla

Prof. shtaywy abdalla

The University of Jordan, Amman, Al ‘Āşimah, Jordan
orcid

Research Focus & Metrics

Academic Career Length

45Years (1982-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 September 2019 in Scientific Reports
Verified
Journal Article
Open access
PDF file
AHAmani A. Harb
Amani A. Harb
YBYasser K. Bustanji
Yasser K. Bustanji
IAIhab M. Almasri
Ihab M. Almasri
SAshtaywy abdalla
shtaywy abdalla
Eugenol, a component of essential oils of medicinal and food plants, has a hypolipidemic effect in experimental animals although its mechanism of action is still unclear. This study aims to explore the mechanism of the hypolipidemic effect of eugenol in rats fed a high cholesterol and fat diet (HCFD). Eugenol significantly reduced total cholesterol (TC), low-density lipoproteins (LDL), atherogenic index (AI) but not high-density lipoproteins (HDL) or triglycerides (TG). Eugenol also decreased steatosis and hepatic inflammation in liver sections, decreased hepatomegaly, and the hepatic marker enzymes alanine aminotransferase (ALT) and alkaline phosphatase (ALP) activity and increased the antioxidant enzymes superoxide dismutase (SOD) and catalase (CAT) activity in hypercholesterolemic rats. Eugenol did not inhibit hepatic 3-hydroxy-3-methyl-glutaryl-CoA (HMG-CoA) reductase but caused down-regulation of transient receptor potential vanilloid (TRPV1) channels in the liver. Docking simulation using fast, rigid exhaustive docking (FRED) software indicated a tail-up/head-down interaction of eugenol with TRPV1 channel. Data indicate that eugenol does not inhibit HMG-CoA reductase but rather induces its action by interaction with TRPV1 channels.

1 May 1999 in Journal of Ethnopharmacology
Verified
Journal Article
Closed access
FAFatma Afifi
Fatma Afifi
EKEnam A. Khalil
Enam A. Khalil
SAshtaywy abdalla
shtaywy abdalla

1 February 2008 in International Immunopharmacology
Verified
Journal Article
Closed access
MFMohammad Fararjeh
Mohammad Fararjeh
MMMohammad K. Mohammad
Mohammad K. Mohammad
YBYasser Bustanji
Yasser Bustanji
HAHatim S AlKhatib
Hatim S AlKhatib
SAshtaywy abdalla
shtaywy abdalla

1 January 2015 in Asian Pacific Journal of Tropical Biomedicine
Verified
Journal Article
Open access
ABAmel Bouaziz
Amel Bouaziz
SKSeddik Khennouf
Seddik Khennouf
MZMussa Abu Zarga
Mussa Abu Zarga
SAshtaywy abdalla
shtaywy abdalla
ABAbderahmane Baghiani
Abderahmane Baghiani
NCNoureddine Charef
Noureddine Charef
ObjectiveTo analyze Myrtus communis chemically and evaluate the hypotensive effects and antioxidant properties of methanol, chloroform, ethyl acetate and aqueous extracts from the leaves of this plant.MethodsTotal phenolic and flavonoid contents as well as the antioxidant potential of methanol, chloroform, ethyl acetate and aqueous extracts have been investigated by using different in vitro methods. The hypotensive effects of methanol and ethyl acetate extracts were evaluated in anaesthetized rats by using the method of invasive blood pressure recording. Moreover, ethyl acetate extract was subjected to analysis by different chromatographic methods in order to identify new compounds.ResultsChemical analysis of ethyl acetate extract revealed the presence of myrecitin-3-O-α-rhamnoside. Ethyl acetate extract was found to have the highest total phenolic and total flavonoid contents with the values of 435.37 mg gallic acid equivalents/g dried weight and 130.75 mg quercetin equivalent/g dried weight, respectively. Ethyl acetate extract also exhibited the highest activity in scavenging 2,2-diphenyl-1-picrylhydrazyl, 2,2'-azinobis-(3-ethylbenzthiazoline-6-sulfonic acid), hydroxyl radical and reducing power; whereas, methanol extract exhibited higher chelating activity than ethyl acetate extract did. Chloroform was found to be strong inhibitor of lipid peroxidation in β-carotene bleaching assay (91.19%), ferric thiocyanate method (87.55%), and thiobarbituric acid method (82.59%) as compared to butylated hydroxytoluene. Intravenous administration of methanol and ethyl acetate extract (0.04 to 12 mg/kg body weight) decreased the maximum mean arterial blood pressure with values of 20.6% and 32.49% at 12 mg/kg body weight, respectively in anesthetized rats.ConclusionsThis study provides a scientific basis for the use of Myrtus communis in traditional medicine as hypertensive agent as well as additional resources for natural antioxidants

1 May 1997 in General Pharmacology: The Vascular System
Verified
Journal Article
Closed access
HHHana M. Hammad
Hana M. Hammad
SAshtaywy abdalla
shtaywy abdalla

1 January 2018 in Journal of Clinical Biochemistry and Nutrition
Verified
Journal Article
Open access
PDF file
AHAmani A. Harb
Amani A. Harb
YBYasser Bustanji
Yasser Bustanji
SAshtaywy abdalla
shtaywy abdalla
Hypercholesterolemia is a major risk factor for cardiovascular diseases. This study investigated the cholesterol-lowering potential of β-caryophyllene in a rat model. Hypercholesterolemia was induced by feeding male Wistar rats a high cholesterol and fat diet for 2 weeks. This was followed by oral administration of β-caryophyllene to hypercholesterolemic rats at 30, 100 and 300 mg/kg b.w. for 4 weeks. A dose of 30 mg/kg of β-caryophyllene significantly lowered serum total cholesterol, low density lipoprotein and the atherogenic index and significantly increased high density lipoprotein level. Moreover, it ameliorated liver injury as evidenced by decreasing hepatomegaly, macrovesicular steatosis and the activity of hepatic marker enzymes alanine aminotransferase and aspartate aminotransferase. Furthermore, it increased the activity of the antioxidant enzyme superoxide dismutase. This dose of β-caryophyllene significantly inhibited the activity of hepatic hydroxy-methylglutaryl coenzyme A reductase. Higher doses (100 and 300 mg/kg) of β-caryophyllene, however, did not induce significant beneficial effects on the studied parameters. These observations demonstrate that β-caryophyllene has a cholesterol-lowering effect on hypercholesterolemic rats, thus offering protection against hypercholesterolemia-induced diseases such as atherosclerosis and fatty liver.